Quality improvement in non glycaemic targets in diabetic patients at Central Australian Aboriginal Congress John Boffa Public Health Medical Officer.

Slides:



Advertisements
Similar presentations
National Service Frameworks Dr Stephen Newell February 2002.
Advertisements

General Practice Workshop This workshop was conceived and developed by Kidney Health Australia’s Kidney Check Australia Taskforce with particular thanks.
Newly diagnosed hypertensive patients with type 2 diabetes (n = 1544) Randomisation Avoid ACE inhibitors/ beta-blockers (n = 390) Tight BP control (n =
National Diabetes Audit (NDA) PARTNERSHIP WORKING WITH PATIENTS AND SERVICE USERS Laura Fargher Diabetes UK.
Produced by The Alfred Workforce Development Team on behalf of DHS Public Health - Diabetes Prevention and Management Initiative June 2005 Diabetes Prevention.
Aggressive Hyperglycemia Management. Significant hospital hyperglycemia requires close follow-up Previously diagnosed diabetes and elevated A1C Without.
BLOOD PRESSURE LOWERING. UKPDS design Aim To determine whether intensified blood glucose control, with either sulphonylurea or insulin, reduces the risk.
PAD A Call to Action. PAD: A Call to Action - What is peripheral arterial disease (PAD)? and why is it so dangerous? - Diagnosing PAD in the primary care.
CVD prevention & management: a new approach for primary care Rod Jackson School of Population Health University of Auckland New Zealand.
Absolute cardiovascular disease risk Assessment and Early Intervention Dr Michael Tam Lecturer in Primary Care
Doris Young, John Furler, Christine Walker, Margarite Vale, James Best, Leonie Segal, Trisha Dunning (NHMRC GP clinical research grant July ) PEACH:
Introduction To The Alphabet Strategy And Evidence Based Medicine.
Improving Data Recording in Primary Care Data Michelle Page & Hassy Dattani THIN.
Al-Fada AA & Bin Abdulrahman KA, King Saud University, Riyadh, Saudi Arabia Assessment of Care for Type 2 Diabetic Patients at the PHC Clinics of a Referral.
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
CVD Prevention in Primary Care CVD Guidelines Symposium Wednesday 3 rd Novemeber 2010 Dr John Cox FRCPI FRCGP.
Lifestyle Medicine 101 Presented by ACLM Professionals in Training Executive Board 2014.
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
HYPERLIPIDAEMIA. 4S 4444 patients –Hx angina or MI –Cholesterol Simvastatin 20mg (10-40) vs. placebo FU 5 years  total cholesterol 25%;  LDL.
Rapid E clinical guidance in the management of Type 2 diabetes New Zealand Guidelines Group.
Risk estimation and the prevention of cardiovascular disease SIGN 97.
British Journal of Healthcare Assistants The HCAs Role in Diabetes Management in Primary Care Linda Goldie Clinical Director Primary Care Training Centre.
SHIP Southall Health Improvement Project Presented by Ashok Ganger October Agenda Item 6.
Improving the Quality of Physical Health Checks Kate Dale, Mental/Physical Health Lead BDCT.
Section 6: Management in primary care Particular emphasis on nurse practitioner’s role.
Kotseva K, et al. Eur J Cardiovasc Prev Rehabil 2009 Mar 12 [Epub]
Modern Management of Cholesterol in the High-Risk Patient.
1 NHLBI/NEI National Institutes of Health NHLBI/NEI National Institutes of Health.
Section 5: Configuration of healthcare to manage CKD.
NATIONAL D I ABET ES DEI TACUON PROGRA M Changing the way diabetes is treated.
VA National Center for Health Promotion and Disease Prevention Using USPSTF Recommendations in VHA Clinical Practice Linda Kinsinger, MD, MPH Chief Consultant.
Enrollment and Outcomes Fan Fan Hou, et al. N Engl J Med 2006;354:
Secondary Prevention of CHD in Primary Care. Nurse Led Clinics by Susan Neal Nurse Practitioner North Street Medical Care.
NHS Health Check NHS Health Check Programme in Norfolk Presented by Justine Hottinger.
1 Diabetes-Where to from here ? Prepared by [Lynne Gilks] [CNC Diabetes Education] [Diabetes Centre, Tamworth] [November 2009]
Diabetes: Beyond Sugar. CHAOS C - Coronary artery disease H - Hyper-tension, -glycaemia, -insulinaemia A - Atherosclerosis O - Obesity S - Stroke.
2007 Hypertension as a Public Health Risk January, 2007.
Electronic patient record since SDC Quality of Care Data 2009 – 2011 for Type 1 Diabetes NCQA indicatorGoal HbA1c > 9,0 %≤ 15%
Ross T. Tsuyuki, BSc(Pharm), PharmD, MSc, FCSHP, FACC Yazid NJ Al Hamarneh, BPharm, PhD Charlotte Jones, MD, PhD, FRCP(C) Brenda Hemmelgarn, MD, PhD, FRCP(C)
The Burden of Chronic Diseases in the Developing World Stephen J. Spann, M.D., M.B.A. Professor and Chairman Department of Family and Community Medicine.
DEVELOPING AND IMPLEMENTING CLINICAL GUIDELINES Mauritius 2007 Dr John Riordan
PUTTING PREVENTION FIRST Vascular Checks Dr Bill Kirkup Associate NHS Medical Director.
PUTTING PREVENTION FIRST Vascular Checks/ NHS Health Checks.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Effectiveness of Pharmacist Interventions on.
Circulation. 2014;129: Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy.
NHS Health Check Risk Assessment Process Sue Collins Promoting Health Engagement Lead.
Prevention of diabetes complications The alphabet strategy.
Dr John Cox Diabetes in Primary Care Conference Cork
Diabetes Care Planning Interim Results
The SPRINT Research Group
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials Ungroup once.
NDA – THE LATEST DATA Prof Roger Gadsby MBE FRCGP Honorary Associate Clinical Professor , WMS GP Clinical Lead National Diabetes Audit.
Cholesterol Treatment Trialists’ (CTT) Collaboration Slide deck
The Anglo Scandinavian Cardiac Outcomes Trial
Diabetes Health Status Report
Teaching Tool: Blood Pressure Classification
The Hypertension in the Very Elderly Trial (HYVET)
Insights from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
Glycemic control for macrovascular disease in type II diabetes: Evidence and insights from recent trials  Sanjay Rajagopalan  Journal of Indian College.
Masterclass on lifestyle change How to help patients lose weight?
Adjusted relative risk for developing end-stage renal disease (ESRD) associated with blood-pressure level BP level (mm Hg) Adjusted relative risk 95%
Ratio of relative risks of heart disease and stroke associated with higher blood pressure, smoking, type I and II diabetes, and higher cholesterol in women.
Goals & Guidelines A summary of international guidelines for CHD
Cause of death Treatment-arm events, % (n=45 054)
DENERHTN Trial design: Patients with resistant hypertension were randomized to renal denervation plus standardized stepped-care antihypertensive treatment.
Value Based Healthcare King’s Health Partners
The Heart Truth Delaware Background
PROSPER: trial design                                                                                                                                                                 
Titration activities from baseline up to 6 and 12 months follow-up in nurse-coordinated care (NCC) versus usual care patients. X-as: patients (percentage),
Average change in blood pressure (BP) from recruitment to 6-month postrecruitment in intervention and control patients >50 years included due to having.
Presentation transcript:

Quality improvement in non glycaemic targets in diabetic patients at Central Australian Aboriginal Congress John Boffa Public Health Medical Officer

Introduction 1. A historical perspective 2. NPCC and prioritising outcomes 3. Cholesterol control 4. BP control 5. Treatment for renal disease 6. Brief interventions for SNAP 7. Eyes and Foot Checks 8. What has led to the improvements?

3 historical periods in Diabetes Care in Central Australia Period 1 “Denial” 1988: diabetes but no complications Period 2 “Treatment nihilism” 1994: Scrimgeour and Rowse, Menzies – telling an Aboriginal person they had diabetes was the equivalent of telling a non Aboriginal person they had cancer Period 3 “Hope” 1999: diabetes is preventable and effective treatment from a well resourced PHC sector can make a big difference

Outcomes of improved diabetes management (NPCC) 1 percentage point reduction in HbA1c DCCT. N Engl J Med 1993; 329(14): UKPDS 33. Lancet 1998; 352(9131): % reduction in micro- vascular complications vascular complications 10 mm Hg reduction in blood pressure UKPDS 38. BMJ 1998; 317(7160): % reduction in micro- vascular complications; vascular complications; 44% reduction in strokes; 32% reduction in deaths Improved blood lipid control Pyorala K, et al. Diabetes Care 1997; 20(4): % reduction of coronary heart disease heart disease 43% reduction in death

Cholesterol control

Diabetic cholesterol control

Results: Cholesterol 2006  Total diabetic population n=541  Total cholesterol recorded in 75.8% (n=410)  Of those recorded: –76% Total Cholesterol <5.5 mmol/L –30% Total Cholesterol ≤4.0 mmol/L –Mean Total Cholesterol 4.7 mmol/L. CAAC (541) Remote NT (194) Cape York (252) Torres Strait (921) TC <5.5 76%60%67%46%

Results: Cholesterol 2009  Total diabetic population n = 734  Total cholesterol recorded in 79.8% (n=610)  Of those recorded: –79% Total Cholesterol <5.5 mmol/L –35% Total Cholesterol ≤4.0 mmol/L –Mean Total Cholesterol 4.5 mmol/L.

Patients on statins have doubled

More active management

Blood Pressure Control

Diabetic Blood Pressure Control <130/80

2009 BP outcomes  67% of Diabetic patients (n = 492) have had a BP recorded in the last 6 months  67% of Diabetic patients (n = 492) have had a BP recorded in the last 6 months  Of these patients, 231 or 47% have a BP < 130/80  2006 baseline of about 38% < 130 /80

More BP’s being done

Percentage of patients on medications has increased

Need more active BP management

Renal Disease

ACR / eGFR

More active management

Brief Interventions for smoking and alcohol

Smoking brief interventions

Increased referrals for alcohol

Nutrition and Physical Activity Advice

Eyes, Feet and BMI

Eyes and Feet

BMI

What has led to these improvements? 1. An evidence based focus on prioritised outcomes and scheduled services 2. Regular feedback to practitioners about our performance 3. Improved PIRS functionality: annual cycle of care, recalls, queries, data quality, electronic records 4. An improved pharmacy system ensuring better access to medications 5. An improved clinic system ensuring better access to regular GP for chronic disease management with excellent GP retention 6. Access to a diabetes educator and diabetes nurse 7. Regular physician clinics